Jim Simons Amicus Therapeutics, Inc. Transaction History
Renaissance Technologies LLC
- $63.4 Billion
- Q4 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 2,108,616 shares of FOLD stock, worth $20 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,108,616
Previous 769,300
174.1%
Holding current value
$20 Million
Previous $8.22 Million
141.76%
% of portfolio
0.03%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding FOLD
# of Institutions
312Shares Held
311MCall Options Held
467KPut Options Held
515K-
Vanguard Group Inc Valley Forge, PA29.3MShares$278 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA28.5MShares$270 Million0.05% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$231 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY24.2MShares$230 Million7.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$220 Million3.18% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.66B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...